Trump's 200% pharma tariff blast: How will it affect Indian generic drug companies?

US President Donald Trump has announced heavy import tariffs of up to 200% on generic drugs. Find out what the long-term impact will be on the Indian pharma sector after the 2-year grace period from 1 August 2026, in this detailed report.